Shared-decision making on moderate intensity statin
Indication: Borderline 10-year ASCVD risk: 5-7.4%
Moderate intensity statins: Atorvastatin 10, 20mg Rosuvastatin 5, 10 mg Simvastatin 20-40mg Pravastatin 40, 80mg |
Calculate 10-year ASCVD risk (link in menu)
Follow up Lipid panel in 4-12 weeks Goal LDL reduction: >30% If LDL at goal, monitor every 3-12 months |